Search Contract Opportunities

Ziprasidone Capsules   3

ID: SPE2D2-24-R-0011 • Type: Solicitation • Match:  100%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
Does this contract have any security clearance requirements?
Does this solicitation list any subcontracting requirements?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Ziprasidone Capsules Solicitation

Background
The solicitation is for Ziprasidone Capsules. The Statement of Work (SOW) includes details such as the purpose and objective, purchase compliance, contract price effective date, contract performance date, chargeback agreements, special contract considerations, delivery, transition period, contract duration, ordering and acceptance of orders, initial orders, national contract backorders, product registration, preparation for delivery, labeling, therapeutic equivalence, drug application, manufacturing facilities, recalls, and cost recovery fee and submission of quarterly sales reports.

Work Details
The solicitation number is SPE2D2-24-R-0011. The schedule of supplies/services includes Ziprasidone capsules in various strengths and quantities for the base year and option years. The quantities specified in the schedule are estimates only. The solicitation also contains information on submission instructions via the Defense Logistics Agency Internet Bid Board System (DIBBS), reverse auction notification, subcontracting plan requirements for large business offerors, assessments/reports evaluation by DLA Troop Support for contracts exceeding $250,000.00, and contractor code of business ethics requirements.

Place of Performance
Not explicitly mentioned.

Overview

Agency
DLA Troop Support - Medical [DoD - DLA]
Response Deadline
Aug. 22, 2024, 3:00 p.m. EDT (original: Aug. 15, 2024, 3:00 p.m. EDT) Past Due
Posted
July 16, 2024, 2:57 p.m. EDT (updated: Aug. 15, 2024, 10:39 a.m. EDT)
Set Aside
None
NAICS
325412 - Pharmaceutical Preparation Manufacturing
PSC
6505 - Drugs And Biologicals
Place of Performance
Not Provided
Source
Open
Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
Est. Value Range
Experimental
$1,000,000 - $5,000,000 (AI estimate)
On 7/16/24 DLA Troop Support - Medical issued Solicitation SPE2D2-24-R-0011 for Ziprasidone Capsules due 8/22/24. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Name
Christopher Newman   Profile
Email
christopher.newman@dla.mil
Phone
(215) 737-2905

Secondary Contact

Name
Jason Wray   Profile
Email
jason.wray@dla.mil
Phone
(215) 737-0614

Documents

Posted documents for Solicitation SPE2D2-24-R-0011

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation SPE2D2-24-R-0011

Award Notifications

Agency published notification of awards for Solicitation SPE2D2-24-R-0011

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation SPE2D2-24-R-0011

Similar Active Opportunities

Open contract opportunities similar to Solicitation SPE2D2-24-R-0011

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEFENSE LOGISTICS AGENCY (DLA) > TROOP SUPPORT MEDICAL > DLA TROOP SUPPORT
FPDS Organization Code
97AS-SPE2D2
Source Organization Code
500045947
Last Updated
Sept. 15, 2024
Last Updated By
christopher.newman@dla.mil
Archive Date
Sept. 15, 2024